Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Rejuvenation Research

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/rej.2010.1130PMID 21291297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway.

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.

  2012cited by this paper
• Intrathecal application of autologous bone marrow cell preparations in parkinsonian syndromes

  2012cited by this paper
• A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain.

  2012cited by this paper
• Clinical trials of intranasal delivery for treating neurological disorders – a critical review

  2011cited by this paper
• Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson’s disease

  2011cited by this paper
• Detection of Intranasally Delivered Bone Marrow-Derived Mesenchymal Stromal Cells in the Lesioned Mouse Brain: A Cautionary Report

  2011cited by this paper
• Intranasal delivery of stem cells to the brain

  2011cited by this paper
• Clinical translation of cell transplantation in the brain

  2011cited by this paper
• Brain distribution of ribavirin after intranasal administration.

  2011cited by this paper
• Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons.

  2010cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.

  2010cited by this paper
• 834 Useful Evaluation of Thromboelastography for Coagulation Disorders in Critically Ill Patients

  2010cited by this paper
• Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease

  2010cited by this paper
• Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin

  2009cited by this paper
• Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25.

  2009cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Brain‐derived neurotrophic factor facilitates maturation of mesenchymal stem cell‐derived dopamine progenitors to functional neurons

  2009cited by this paper
• IC‐P‐027: New metabolic understanding into innovative strategies for early diagnostics and therapy of Alzheimer's disease

  2009cited by this paper
• Intracerebral Transplantation of Bone Marrow‐Derived Mesenchymal Stem Cells Reduces Amyloid‐Beta Deposition and Rescues Memory Deficits in Alzheimer's Disease Mice by Modulation of Immune Responses

  2009cited by this paper
• Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements

  2008cited by this paper
• Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia

  2008cited by this paper
• Disparate Host Response and Donor Survival After the Transplantation of Mesenchymal or Neuroectodermal Cells to the Intact Rodent Brain

  2007cited by this paper
• Angiotensin Receptor Type 1 Blockade in Astroglia Decreases Hypoxia-Induced Cell Damage and TNF Alpha Release

  2007cited by this paper
• Transplantation of a Novel Human Cord Blood-Derived Neural-Like Stem Cell Line in a Rat Model of Cortical Infarct

  2007cited by this paper
• Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and Glia

  2006cited by this paper
• Behavioral models of Parkinson's disease in rodents: A new look at an old problem

  2006cited by this paper
• Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.

  2006cited by this paper
• Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells

  2006cited by this paper
• MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy.

  2006cited by this paper
• Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease

  2005cited by this paper
• Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction

  2005cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Lentivirally generated eGFP‐transgenic rats allow efficient cell tracking in vivo

  2004cited by this paper
• Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve Injury

  2004cited by this paper
• Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat

  2003cited by this paper
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer’s disease

  2003cited by this paper
• Enhancement of Sensorimotor Behavioral Recovery in Hemiparkinsonian Rats with Intrastriatal, Intranigral, and Intrasubthalamic Nucleus Dopaminergic Transplants

  2001cited by this paper
• Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease.

  2001cited by this paper
• Forced Limb-Use Effects on the Behavioral and Neurochemical Effects of 6-Hydroxydopamine

  2001cited by this paper
• Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats.

  2001cited by this paper
• Cytokines in Parkinson's disease.

  2000cited by this paper
• State‐dependent blockade of haloperidol‐induced sensitization of catalepsy by MK‐801

  1999cited by this paper
• Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning.

  1996cited by this paper
• The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.

  1996cited by this paper
• Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

  1995cited by this paper
• Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model.

  1994cited by this paper
• Macrophages and inflammation in the central nervous system.

  1993cited by this paper
• Neural transplantation: problems and prospects for therapeutic application.

  1992cited by this paper
• Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical study.

  1991cited by this paper
• Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes

  1991cited by this paper
• Cortical hypoperfusion as a possible cause of 'subcortical aphasia'.

  1986cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• A rapid method for the regional dissection of the rat brain.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

  1970cited by this paper

• Mesenchymal Stem Cell-Based Therapies Applied in Neurological Diseases: A Systematic Review.

  2026cites this paper
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• MRI-guided focused ultrasound for treating Parkinson’s disease with human mesenchymal stem cells

  2025cites this paper
• Safety of ribavirin in cockatiels (Nymphicus hollandicus) – a preliminary study

  2025cites this paper
• Intranasal empagliflozin-loaded PLGA nanoparticles demonstrate neuroprotective effects against methotrexate-induced chemobrain in rats

  2025cites this paper
• Nasal Nanotherapeutics for Central Nervous System Disorders: Bridging the Translational Gap in Central Nervous System Drug Delivery.

  2025cites this paper
• Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial

  2025cites this paper
• Intranasal Administration of Human Neural Crest-Derived Nasal Turbinate Stem Cells Attenuates Microglia Activity in Mild Head Trauma Models

  2025cites this paper
• Potential Convergence of Olfactory Dysfunction in Parkinson's Disease and COVID-19: The Role of Neuroinflammation.

  2024cites this paper
• Intranasal administration of mesenchymal stem cells overexpressing FGF21 demonstrates therapeutic potential in experimental Parkinson's disease

  2024cites this paper
• The Distinction Between Treatment Approaches in Past, Present, and Future of Parkinson’s Disease

  2024cites this paper
• The prospective role of mesenchymal stem cells in Parkinson's disease.

  2024cites this paper
• Research progress on intranasal treatment for Parkinson's disease

  2024cites this paper
• Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.

  2024cites this paper
• Effect of Intranasal Administration of Adipose-Derived Mesenchymal Stem Cells on Acute Demyelination in Mouse Corpus Callosum

  2024cites this paper
• Mesenchymal Stem Cell-Induced Neuroprotection in Pediatric Neurological Diseases: Recent Update of Underlying Mechanisms and Clinical Utility

  2024cites this paper
• Safety and efficacy outcomes after intranasal administration of neural stem cells in cerebral palsy: a randomized phase 1/2 controlled trial

  2023cites this paper
• Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)

  2023cites this paper
• Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis

  2023influential citation
• Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisks.

  2023cites this paper
• Routes and methods of neural stem cells injection in cerebral ischemia

  2023cites this paper
• Intranasal delivery of stem cells labeled by nanoparticles in neurodegenerative disorders: Challenges and opportunities.

  2023cites this paper
• Intranasal delivery of biotechnology-based therapeutics.

  2022cites this paper
• Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells

  2022cites this paper
• Photobiomodulation Therapy and Cell Therapy Improved Parkinson's Diseases by Neuro-regeneration and Tremor Inhibition.

  2022cites this paper
• Formulation considerations for improving intranasal delivery of CNS acting therapeutics.

  2022cites this paper
• Intranasal interferon-beta as a promising alternative for the treatment of Alzheimer's disease

  2022cites this paper
• Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders

  2022influential citation
• Can Intranasal Administration of Adipose-Derived Stem Cells Reach and Affect the Histological Structure of Distant Organs of Aged Wistar Rat?

  2022cites this paper
• Human umbilical cord-derived mesenchymal stem cells promote repair of neonatal brain injury caused by hypoxia/ischemia in rats

  2022influential citation
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Intranasally applied human olfactory mucosa neural progenitor cells migrate to damaged brain regions

  2022cites this paper
• Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions

  2022cites this paper
• Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities

  2022cites this paper
• Intranasal application of stem cells and their derivatives as a new hope in the treatment of cerebral hypoxia/ischemia: a review

  2022cites this paper
• From Transcriptome to Behavior: Intranasal Injection of Late Passage Human Olfactory Stem Cells Displays Potential in a Rat Model of Parkinson's Disease.

  2021cites this paper
• Direct differentiation of tonsillar biopsy-derived stem cells to the neuronal lineage

  2021cites this paper
• Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine

  2021cites this paper
• Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause

  2021cites this paper
• Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?

  2021cites this paper
• Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson’s Disease Treatment

  2021influential citation
• Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease

  2021cites this paper
• Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease

  2021cites this paper
• Stem cell in neurodegenerative disorders; an emerging strategy

  2021cites this paper
• Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment

  2021cites this paper
• siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.

  2021cites this paper
• The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson’s disease

  2021cites this paper
• Advances in intranasal application of stem cells in the treatment of central nervous system diseases

  2021influential citation
• Rebuilding hippocampus neural circuit with hADSC-derived neuron cells for treating ischemic stroke

  2021cites this paper
• Emerging trends in the delivery of nanoformulated oxytocin across Blood-Brain Barrier.

  2021cites this paper
• Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus

  2021cites this paper
• Nanotechnological advances in direct nose-to-brain drug delivery for neurodegenerative disorders and other neuroailments

  2021cites this paper
• Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.

  2021cites this paper
• Mesenchymal Stem Cells for Neurological Disorders

  2021cites this paper
• Intranasal delivery of mesenchymal stem cells‐derived extracellular vesicles for the treatment of neurological diseases

  2021cites this paper
• Stem cell-based models and therapies: a key approach into schizophrenia treatment

  2021cites this paper
• Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease

  2020influential citation
• Parkinson’s disease treatment: past, present, and future

  2020cites this paper
• Hydrogels based on gellan gum in cell delivery and drug delivery

  2020cites this paper
• Intranasal Insulin: a Treatment Strategy for Addiction

  2020cites this paper
• Development and Characterization of Levodopa Loaded Pharmacosomes for Brain Targeting via Intranasal Route: Pharmacodynamic Evaluation in Rats

  2020cites this paper
• Clinical potential and current progress of mesenchymal stem cells for Parkinson’s disease: a systematic review

  2020cites this paper
• Imaging of intranasal drug delivery to the brain.

  2020cites this paper
• PROS SEM NAS MASY BIODIV INDON

  2020cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Review Imaging of intranasal drug delivery to the brain

  2020cites this paper
• Beyond the Hippocampus and the SVZ: Adult Neurogenesis Throughout the Brain

  2020cites this paper
• Role of mesenchymal stem cells in central nervous system regenerative medicine: past, present, and future

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• Cell motility and migration as determinants of stem cell efficacy

  2020cites this paper
• Synergistic effect of electric stimulation and mesenchymal stem cells against Parkinson's disease

  2020cites this paper
• Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

  2020cites this paper
• Modulating endothelial adhesion and migration impacts stem cell therapies efficacy

  2020cites this paper
• Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.

  2020cites this paper
• Modulation of Stem Cells as Therapeutics for Severe Mental Disorders and Cognitive Impairments

  2020cites this paper
• Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation

  2020cites this paper
• MSCs Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

  2020cites this paper
• Dental stem cells as a promising source for cell therapies in neurological diseases

  2019cites this paper
• Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice

  2019influential citation
• The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson’s Disease Model

  2019cites this paper
• Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica

  2019cites this paper
• Changes in the Immune System in Parkinson’s Disease

  2019cites this paper
• C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation

  2019cites this paper
• Mesenchymal stem cell transplantation and aerobic exercise for Parkinson’s disease: therapeutic assets beyond the motor domain

  2019cites this paper
• [Optimization of the theoretical model for growth rate of mesenchymal stem cells on three-dimensional scaffold under fluid shear stress].

  2019cites this paper
• Cranial Pair I: The Olfactory Nerve

  2019cites this paper
• Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson’s disease therapy

  2019cites this paper
• Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease

  2019cites this paper
• Nasal route for vaccine and drug delivery: features and current opportunities.

  2019cites this paper
• Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application

  2019cites this paper
• Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies

  2018cites this paper
• Intranasal Stem Cell Treatment as a Novel Therapy for Subarachnoid Hemorrhage

  2018cites this paper
• Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models

  2018cites this paper
• Mesenchymale Stromazellen auf demWeg zur klinischen Anwendung : Update 2018 Mesenchymal Stromal Cells on Their Way from Bench to Bedside : Update 2018

  2018cites this paper
• Stem cell‐based therapy for Parkinson’s disease with a focus on human endometrium‐derived mesenchymal stem cells

  2018cites this paper
• The Promising Effects of Transplanted Umbilical Cord Mesenchymal Stem Cells on the Treatment in Traumatic Brain Injury

  2018cites this paper
• Stem cell-secreted 14,15- epoxyeicosatrienoic acid rescues cholesterol homeostasis and autophagic flux in Niemann–Pick-type C disease

  2018cites this paper
• Stem Cell Therapy of Gliomas.

  2018cites this paper